Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABO-1009DP by Suzhou Abogen Biosciences for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
ABO-1009DP is under clinical development by Suzhou Abogen Biosciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According...